Product image of Ipratropium/Salbutamol Orion (Salbutamol, Ipratropium Bromide Monohydrate) supplied by GNH India

Ipratropium/Salbutamol Orion

Active Ingredient:
Salbutamol, Ipratropium Bromide Monohydrate
Origin:
EU

Ipratropium/Salbutamol Orion (Salbutamol, Ipratropium Bromide Monohydrate)

Salbutamol, the active ingredient in Ipratropium/Salbutamol Orion, is a β2‑adrenergic agonist presented as a combined oral formulation for oral use. It is used to relax airway smooth muscle and improve breathing in patients with obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD).

GNH India supplies Ipratropium/Salbutamol Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipratropium/Salbutamol is a bronchodilator indicated for conditions involving reversible airway obstruction.

  • Asthma: provides rapid relief of bronchospasm and improves airflow during acute episodes.
  • Chronic obstructive pulmonary disease (COPD): helps reduce airway resistance and ease breathing in stable disease.
  • Acute bronchospasm: used to quickly open airways during sudden worsening of respiratory symptoms.

How It Works

  • The combination product works by two complementary mechanisms: salbutamol stimulates β2‑adrenergic receptors on bronchial smooth muscle, leading to cyclic AMP‑mediated relaxation, while ipratropium bromide blocks muscarinic M3 receptors, preventing acetylcholine‑induced bronchoconstriction. Together they produce additive bronchodilation and improve airway patency.

Side Effects

Adverse reactions may occur with any bronchodilator therapy.

Common Side Effects

  • Tremor: mild shaking of hands or limbs.
  • Headache: transient headache episodes.
  • Dry mouth: reduced salivation causing discomfort.
  • Palpitations: sensation of rapid or irregular heartbeat.
  • Nausea: mild gastrointestinal upset.
  • Cough: irritation of the airway.

Serious or Rare Side Effects

  • Paradoxical bronchospasm: worsening of breathing difficulty.
  • Angioedema: swelling of lips, tongue or throat.
  • Severe tachycardia: markedly increased heart rate.
  • Hypokalemia: low blood potassium levels.
  • Allergic reaction: rash, itching, or anaphylaxis.
  • Cardiac arrhythmia: abnormal heart rhythm.

Precautions & Warnings

Before using Ipratropium/Salbutamol, consider the following safety measures.

  • Assess cardiac history: patients with heart disease should be monitored.
  • Review electrolyte status: low potassium may increase risk of arrhythmias.
  • Evaluate for glaucoma: anticholinergic component can raise intra‑ocular pressure.
  • Monitor for paradoxical bronchospasm: discontinue if breathing worsens.
  • Use with caution in pregnancy: only if benefit outweighs risk.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Drug interactions can modify the safety or effectiveness of Ipratropium/Salbutamol.

Major Interactions (Avoid)

  • Beta‑blockers: may diminish bronchodilator response and precipitate bronchospasm.
  • Diuretics (e.g., furosemide): increase risk of hypokalemia, enhancing cardiac effects.
  • MAO inhibitors: can potentiate sympathomimetic effects of salbutamol.

Moderate Interactions (Monitor Closely)

  • Anticholinergic drugs (e.g., atropine): additive dry‑mouth and ocular pressure effects.
  • Theophylline: may increase risk of tachyarrhythmias.
  • Corticosteroids: monitor for enhanced systemic effects when combined with high‑dose inhaled therapy.

Frequently Asked Questions

Ipratropium/Salbutamol Orion is a combined bronchodilator indicated for the relief of bronchospasm in asthma, chronic obstructive pulmonary disease (COPD), and other conditions characterized by reversible airway obstruction. It works by relaxing airway smooth muscle to improve breathing.

Salbutamol, a β2‑adrenergic agonist, binds to β2 receptors on bronchial smooth muscle, activating adenylate cyclase and increasing cyclic AMP. This cascade leads to muscle relaxation and bronchodilation, helping to open narrowed airways.

The prescribed dose of Ipratropium/Salbutamol Orion is determined by the treating clinician based on the patient’s condition, severity, and response. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety in pregnancy and lactation has not been definitively established. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with single‑agent bronchodilators, the combination offers additive bronchodilation by targeting both β2‑adrenergic and muscarinic pathways. This can provide faster symptom relief and improved lung function in patients who need dual mechanisms, whereas monotherapy may be less effective in severe obstruction.

Store the product below 25 °C in its original packaging, protecting it from moisture and direct sunlight. Do not expose the medication to extreme temperatures or humidity, as this may affect its stability and potency.

Ipratropium/Salbutamol Orion is taken orally as directed by the prescriber. The tablet or liquid should be swallowed with water, and the patient should follow any specific instructions regarding timing relative to meals or other medications.

Serious risks include paradoxical bronchospasm, severe tachycardia, angioedema, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience worsening breathing, rapid heartbeat, swelling of the face or throat, or any signs of an allergic reaction.

Individuals with known hypersensitivity to salbutamol, ipratropium, or any excipients in the formulation should avoid this product. It is also contraindicated in patients with severe narrow‑angle glaucoma or urinary retention caused by anticholinergic effects, unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Salbutamol, Ipratropium Bromide Monohydrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT